The news. The narrative. The timeline.
More than 15,000 measles cases in early 2026, a 32-times surge in 2025, and a November elimination-status review now sit on the same calendar as Andersen's domestic-spread genomes.
The review said trivial benefit; the institutions paying for the drugs have answered with something louder than a rebuttal.
The helium story has grown up from hospital worry into a boring design question with life-or-death consequences.
The party balloon explains ignition; it does not explain whether command can manage a drought fire across county lines.
Five days after the NEST coverage opened, the $5,000 baby bonus remains a slogan with no bill, no eligibility rule, and no payment architecture.
Eight days after WashU published an eight-country young-adult loneliness study, NIH and the Surgeon General's Office have offered no policy response.
Day four of the Idaho dairy H5N1 outbreak ends with no Sunday USDA expansion artifact and quarantine boundaries trailing the public outbreak map.
Eight days after the 2026 Boston Marathon, the BAA's results page still privileges elite winners over the 80-plus finishers visible only via filtered search.
Regeneron's free-in-US pledge for Otarmeni and the FDA's June 4 CNPV public hearing turn a 61-day approval into a live access and pricing test.
Day three of Vance's Communion memoir rollout overlaps Pope Leo's capital-punishment rebuke and the administration's firing-squad executive order.
Two pine landscapes, one drought spring — New Jersey remembers Jones Road while Georgia watches Pineland Road eat 32,003 acres.
Glynn County stops watching smoke and starts moving residents — road closures Sunday tied its evacuation logistics to the Brantley-Wayne fire zone.
A 17-year record of 23 right whale calves and a Canadian ghost-gear investigation are the same recovery equation, not separate stories.
Printed neurons that activate living brain cells reframe AI's energy bill as a biology problem — the brain is five orders of magnitude more efficient than silicon.
An SP8/FGF8 paper traces limb regeneration across mouse, zebrafish and axolotl — proof of principle, not a cure.